Sage Journals: Discover world-class research

Abstract

Neonatal hyperbilirubinemia is a common clinical condition caused mainly by the increased production and decreased excretion of bilirubin. Current treatment is aimed at reducing the serum levels of bilirubin. Heme oxygenase-1 (HO-1) is a rate-limiting enzyme that generates bilirubin. In this study we intended to suppress HO-1 using the RNA interference technique. Small interfering RNA (siRNA)-A, -B, and -C were designed based on human HO-1 (hHO-1) mRNA sequences. siRNA was transfected into a human hepatic cell line (HL-7702). hHO-1 transcription and protein levels were then determined. In addition, the inhibitory effect of siRNA on hHO-1 was assessed in cells treated with hemin or transfected with an hHO-1 plasmid. siRNA-C showed the most potent suppressive effect on hHO-1. This inhibition is dose and time dependent. Compared with control, both hemin and hHO-1 plasmids up-regulated hHO-1 expression in HL-7702 cells. However, the up-regulation was significantly attenuated by siRNA-C. Furthermore, the decrease in hHO-1 activity was coincident with the suppression of its transcription. Finally, siRNA-C was shown to reduce hHO-1 enzymatic activity and bilirubin levels. Thus, this study provides a novel therapeutic rationale by blocking bilirubin formation via siRNA for preventing and treating neonatal hyperbilirubinemia and bilirubin encephalopathy at an early clinical stage.

Get full access to this article

View all access options for this article.

References

Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol 7:111–119, 2002.

Riskin A, Kugelman A, Abend-Weinger M, Green M, Hemo M, Bader D. In the eye of the beholder: how accurate is clinical estimation of jaundice in newborns? Acta Paediatr 92:574–576, 2003.

Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol 7:135–141, 2002.

Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyper-bilirubinaemia in the era of genomics. Semin Neonatol 7:143–152, 2002.

Drummond GS, Kappas A. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest 74:142–149, 1984.

Alexander D. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 113:135, 2004.

Sharp PA. RNA interference. Genes Dev 15:485–490, 2001.

Hannon GJ. RNA interference. Nature 418:244–251, 2002.

Alisky JM, Davidson BL. Towards therapy using RNA interference. AM J Pharmacogenomics 4:45–51, 2004.

10.

Xia ZW, Qi Q, Zhang XH, Shen QX, Li YZ, Yu SC. The study on the construction of expression plasmid containing rHO-1 cDNA, analysis of rHO-1 activity and function of anti-apoptosis in HUVEC. Shi Yan Sheng Wu Xue Bao 38:441–446, 2005.

11.

Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148–18153, 1992.

12.

Sarici SU, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, Yurdakok M, Yigit S. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 113:775–780, 2004.

13.

Setia S, Villaveces A, Dhillon P, Mueller BA. Neonatal jaundice in Asian, white, and mixed-race infants. Arch Pediatr Adolesc Med 156: 276–279, 2002.

14.

Agarwal R, Deorari AK. Unconjugated hyperbilirubinemia in newborns: current perspective. Indian Pediatr 39:30–42, 2002.

15.

Maines MD, Gibbs PE. 30 some years of heme oxygenase: from a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events. Biochem Biophys Res Commun 338:568–577, 2005.

16.

Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 88:F459–F463, 2003.

17.

Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 344:581–590, 2001.

18.

Hansen TW. Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate. Expert Opin Pharmacother 4:1939–1948, 2003.

19.

Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 144:626–631, 2004.

20.

Dani C, Masini E, Bertini G, di Felice AM, Pezzati M, Ciofini S, Rossetti M, Gallori G, Ciuti R, Buonocore G, Paffetti P, Mannaioni PF, Rubaltelli FF. Role of heme oxygenase and bilirubin in oxidative stress in preterm infants. Pediatr Res 56:873–877, 2004.

21.

Zampetaki A, Minamino T, Mitsialis SA, Kourembanas S. Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp Biol Med (Maywood) 228:442–446, 2003.

22.

Dennery PA. Metalloporphyrins for the treatment of neonatal jaundice. Curr Opin Pediatr 17:167–169, 2005.

23.

Saetrom P, Snove O Jr. A comparison of siRNA efficacy predictors. Biochem Biophys Res Commun 321:247–253, 2004.

24.

Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res 33:1671–1677, 2005.

25.

Persengiev SP, Zhu X, Green MR. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12–18, 2004.

26.

Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30:1757–1766, 2002.

27.

Drummond GS, Kappas A. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest 74:142–149, 1984.

28.

Onodera Y, Takahashi K, Togashi T, Sugai Y, Tamaki N, Miyasaka K. Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases—validation of the use of SPECT and a new indicator. Ann Nucl Med 17:181–188, 2003.

Reduction of Bilirubin by Targeting Human Heme Oxygenase-1 Through siRNA

Abstract

Get full access to this article

References